Patrick Baeuerle

2020

In 2020, Patrick Baeuerle earned a total compensation of $5.4M as Acting Chief Scientific Officer at Cullinan Therapeutics.

Compensation breakdown

Bonus$266,131
Option Awards$4,124,284
Salary$436,997
Stock Awards$491,284
Other$34,800
Total$5,353,496

Baeuerle received $4.1M in option awards, accounting for 77% of the total pay in 2020.

Baeuerle also received $266.1K in bonus, $437K in salary, $491.3K in stock awards and $34.8K in other compensation.

Rankings

In 2020, Patrick Baeuerle's compensation ranked 2,026th out of 13,090 executives tracked by ExecPay. In other words, Baeuerle earned more than 84.5% of executives.

ClassificationRankingPercentile
All
2,026
out of 13,090
85th
Division
Manufacturing
782
out of 5,618
86th
Major group
Chemicals And Allied Products
280
out of 2,251
88th
Industry group
Drugs
236
out of 1,951
88th
Industry
Biological Products, Except Diagnostic Substances
70
out of 411
83rd
Source: SEC filing on April 29, 2022.

Baeuerle's colleagues

We found two more compensation records of executives who worked with Patrick Baeuerle at Cullinan Therapeutics in 2020.

2020

Owen Hughes

Cullinan Therapeutics

Chief Executive Officer

2020

Jeffrey Trigilio

Cullinan Therapeutics

Chief Financial Officer

News

In-depth

You may also like